BACKGROUND Knowledge about the travel-associated risks of hepatitis A and B, and the extent of pre-travel health-advice being sought may vary between countries. METHODS An online survey was undertaken to assess the awareness, advice-seeking behaviour, rates of vaccination against hepatitis A and B and adherence rates in Australia, Finland, Germany, Norway, Sweden, the UK and Canada between Au...

background human immunodeficiency virus (hiv) infected patients are also frequently exposed to the hepatitis b virus (hbv), due to the common routes of transmission, therefore, prevention of hepatitis b results in decreased complications of the disease. objectives since the immune response of hiv patients to hepatitis b vaccination is less robust than that found in healthy individuals, this stu...

background: available drugs are not able to eradicate intracellular viral dna in patients with hepatitis b virus (hbv) infections. hbsag vaccine could induce immunity and subsequently eradicate hepatitis b virus in proportions of these patients. our aim was to evaluate the efficacy of hbsag as a mode of therapy in inactive carriers. materials and methods: forty two consecutive patients of inact...

10 Ten years have elapsed since routine vaccination of infants and of 12-year-old adolescent was implemented in Italy. 11 In this period, evidence has accumulated on the epidemiological impact of universal immunisation. 12 Coverage is on average >90% and is ≥95% in many areas of the country. Incidence of acute hepatitis B, that was already declining before 1991, was further decreased by routine...

Despite the availability of a safe and effective vaccine since 1982, overall coverage of hepatitis B vaccination among healthcare workers (HCWs) has not reached a satisfactory level in many countries worldwide. The aim of this study was to estimate the prevalence of hepatitis B vaccination, and to assess the predictors of hepatitis B vaccination status among HCWs in Serbia. Of 380 randomly sele...

background: different studies have demonstrated that a small proportion of healthy individuals receiving the hepatitis b (hb) vaccine do not produce protective levels of anti-hb antibody, a phenomenon which could be linked to certain human leukocyte an-tigen (hla) class-ii alleles or haplotypes. objectives: the present study was under-taken to determine the frequency of hla class-ii alleles in ...